SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction

Abstract Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of...

Full description

Saved in:

Bibliographic Details
Published in:	Briefings in bioinformatics Vol. 24; no. 1
Main Authors:	Li, Tian-Hao, Wang, Chun-Chun, Zhang, Li, Chen, Xing
Format:	Journal Article
Language:	English
Published:	England Oxford University Press 19.01.2023 Oxford Publishing Limited (England)
Subjects:	Anticancer properties Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antineoplastic drugs Artificial neural networks Cancer Computational Biology - methods Computer applications Computer Simulation Correlation coefficient Correlation coefficients Drug Combinations Drug Synergism In vitro methods and tests Information processing Multilayer perceptrons Multilayers Predictions Software Toxicity Siamese network synergistic drug combination random matrix projection cell line drug
ISSN:	1467-5463, 1477-4054, 1477-4054
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Abstract Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high-throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi-layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean-squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5-fold cross-validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91 ± 0.03 and the AUPR of 0.62 ± 0.05 in 5-fold cross-validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations.
AbstractList	Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high-throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi-layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean-squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5-fold cross-validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91 ± 0.03 and the AUPR of 0.62 ± 0.05 in 5-fold cross-validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations. Abstract Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high-throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi-layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean-squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5-fold cross-validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91 ± 0.03 and the AUPR of 0.62 ± 0.05 in 5-fold cross-validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations. Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high-throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi-layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean-squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5-fold cross-validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91 ± 0.03 and the AUPR of 0.62 ± 0.05 in 5-fold cross-validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations.Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high-throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi-layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean-squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5-fold cross-validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91 ± 0.03 and the AUPR of 0.62 ± 0.05 in 5-fold cross-validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations.
Author	Li, Tian-Hao Zhang, Li Chen, Xing Wang, Chun-Chun
Author_xml	– sequence: 1 givenname: Tian-Hao surname: Li fullname: Li, Tian-Hao email: tianhaoli@cumt.edu.cn – sequence: 2 givenname: Chun-Chun orcidid: 0000-0002-6795-4007 surname: Wang fullname: Wang, Chun-Chun email: ts17060063a3@cumt.edu.cn – sequence: 3 givenname: Li surname: Zhang fullname: Zhang, Li email: TB20060015B4@cumt.edu.cn – sequence: 4 givenname: Xing orcidid: 0000-0001-9028-5342 surname: Chen fullname: Chen, Xing email: xingchen@amss.ac.cn
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36418927$$D View this record in MEDLINE/PubMed
BookMark	eNp9kV1rFDEUhoO02A-98l4CghRkbLInM5nxrmzVFuoHVq9DPs6UrDPJmsyg_RH-52a725si3iQhPM85h_cckb0QAxLygrO3nHVwarw5NUbbmsETcsiFlJVgtdjbvBtZ1aKBA3KU84qxBZMtf0oOoBG87RbykPy9_vzt09ez5fnyHbVxXM-TnnwMeqBjdDjQPto5o6Mx0GuvR8xIA06_Y_pJdXA0lSOOdNRT8n_oOsUV2o1fvFSAyVsdLCaabwOmG5_LB3Vpvtn0Mj7c9yoaOn-vPSP7vR4yPt_dx-THh_fflxfV1ZePl8uzq8qCaKfKuBZk42reawDXMGk40-A61-resKbF2jrsYNGgMSi1MFZ0zEDfWS1kjQDH5GRbt0z8a8Y8qdFni8OgA8Y5q4WETgouu7agrx6hqzinElBWwDmIhkuoC_VyR81mRKfWyY863aqHoAvAt4BNMeeEvbJ-G_WUtB8UZ2qzTFWWqXbLLM6bR85D2X_Tr7d0nNf_Be8A1M6xPw
CitedBy_id	crossref_primary_10_1038_s41598_025_93952_z crossref_primary_10_1109_JBHI_2023_3335275 crossref_primary_10_1186_s12859_024_05705_w crossref_primary_10_1002_ctd2_317 crossref_primary_10_1111_jcmm_70572 crossref_primary_10_1111_jcmm_18372 crossref_primary_10_1111_jcmm_18571 crossref_primary_10_1038_s41598_024_54409_x crossref_primary_10_1016_j_compbiolchem_2024_108054 crossref_primary_10_1016_j_compbiolchem_2024_108175 crossref_primary_10_1021_acs_jcim_4c00003 crossref_primary_10_1093_bib_bbae481 crossref_primary_10_1093_bib_bbad097 crossref_primary_10_1093_bioinformatics_btaf326 crossref_primary_10_1109_JBHI_2023_3342280 crossref_primary_10_3389_fmicb_2023_1207209 crossref_primary_10_1093_bib_bbad328 crossref_primary_10_1109_JBHI_2024_3491318 crossref_primary_10_1016_j_sbi_2024_102827 crossref_primary_10_1038_s41598_024_52814_w crossref_primary_10_1016_j_compbiomed_2025_110788 crossref_primary_10_1093_nar_gkae791 crossref_primary_10_1016_j_jbi_2025_104843 crossref_primary_10_1093_bib_bbad522 crossref_primary_10_1109_JBHI_2024_3434439 crossref_primary_10_1109_TAI_2023_3314405 crossref_primary_10_1109_TCBB_2024_3417715 crossref_primary_10_1109_JBHI_2024_3372527 crossref_primary_10_1021_acs_jcim_4c02276 crossref_primary_10_1093_bib_bbad120 crossref_primary_10_1109_JBHI_2024_3375025 crossref_primary_10_1109_TCBBIO_2024_3502507 crossref_primary_10_1049_syb2_70020 crossref_primary_10_1109_TCBB_2024_3385796 crossref_primary_10_1016_j_compbiomed_2023_107137 crossref_primary_10_1016_j_cmpb_2025_108933 crossref_primary_10_2174_1574893618666230227105703 crossref_primary_10_1109_JBHI_2023_3306768
Cites_doi	10.1016/j.cell.2017.05.038 10.1038/s41467-019-09186-x 10.1038/nbt.2391 10.1023/A:1010933404324 10.1056/NEJMra1510062 10.1038/nrd2424 10.1093/bib/bbab355 10.3389/fgene.2019.00600 10.1142/S0218001493000339 10.1371/journal.pcbi.1006752 10.1371/journal.pcbi.1005308 10.1038/s41576-019-0122-6 10.1016/j.drudis.2015.09.003 10.1371/journal.pcbi.1004975 10.1158/1535-7163.MCT-15-0843 10.1093/bioinformatics/btz411 10.1124/jpet.106.104117 10.1016/j.cell.2016.06.017 10.1038/nrd2683 10.1200/JCO.2008.19.8135 10.1016/j.csbj.2015.09.001 10.1158/0008-5472.CAN-06-4495 10.1023/A:1008342013224 10.1093/bioinformatics/bty573 10.1109/JBHI.2018.2852274 10.1093/bioinformatics/btl033 10.3892/or.2016.5315 10.1124/pr.58.3.10 10.1093/bioinformatics/btx806 10.1093/bioinformatics/btw230 10.1093/bib/bbw104 10.1016/j.pharmthera.2013.01.016 10.1056/NEJMoa1413513 10.1038/nbt.2284 10.1001/jama.285.16.2083 10.1007/s00204-015-1587-5 10.1093/bib/bbab534 10.1093/bioinformatics/btt105
ContentType	Journal Article
Copyright	The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2022 The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com
Copyright_xml	– notice: The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2022 – notice: The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. – notice: The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7SC 8FD FR3 JQ2 K9. L7M L~C L~D P64 RC3 7X8
DOI	10.1093/bib/bbac503
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Computer and Information Systems Abstracts Technology Research Database Engineering Research Database ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Biotechnology Research Abstracts Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest Computer Science Collection Computer and Information Systems Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Advanced Technologies Database with Aerospace Biotechnology and BioEngineering Abstracts Computer and Information Systems Abstracts Professional MEDLINE - Academic
DatabaseTitleList	CrossRef Genetics Abstracts MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	1477-4054
ExternalDocumentID	36418927 10_1093_bib_bbac503 10.1093/bib/bbac503
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: National Natural Science Foundation of China grantid: 11631014
GroupedDBID	--- -E4 .2P .I3 0R~ 1TH 23N 2WC 36B 4.4 48X 53G 5GY 5VS 6J9 70D 8VB AAGQS AAHBH AAIJN AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPQZ AAPXW AARHZ AAUQX AAVAP AAVLN ABDBF ABEJV ABEUO ABGNP ABIXL ABNKS ABPQP ABPTD ABQLI ABQTQ ABWST ABXVV ABXZS ABZBJ ACGFO ACGFS ACGOD ACIWK ACPRK ACUFI ACUHS ACUXJ ACYTK ADBBV ADEYI ADFTL ADGKP ADGZP ADHKW ADHZD ADOCK ADPDF ADQBN ADRDM ADRTK ADVEK ADYVW ADZTZ ADZXQ AECKG AEGPL AEGXH AEJOX AEKKA AEKSI AELWJ AEMDU AEMOZ AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFRAH AGINJ AGKEF AGQXC AGSYK AHMBA AHQJS AHXPO AIAGR AIJHB AJEEA AJEUX AKHUL AKVCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALTZX ALUQC ALXQX AMNDL ANAKG APIBT APWMN ARIXL AXUDD AYOIW AZVOD BAWUL BAYMD BEYMZ BHONS BQDIO BQUQU BSWAC BTQHN C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EAD EAP EAS EBA EBC EBD EBR EBS EBU EE~ EJD EMB EMK EMOBN EST ESX F5P F9B FHSFR FLIZI FLUFQ FOEOM FQBLK GAUVT GJXCC GROUPED_DOAJ GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ K1G KBUDW KOP KSI KSN M-Z M49 MK~ ML0 N9A NGC NLBLG NMDNZ NOMLY NU- O0~ O9- OAWHX ODMLO OJQWA OK1 OVD OVEED P2P PAFKI PEELM PQQKQ Q1. Q5Y QWB RD5 RPM RUSNO RW1 RXO SV3 TEORI TH9 TJP TLC TOX TR2 TUS W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ZL0 ~91 77I AAYXX AHGBF CITATION ROX ADRIX AFXEN BCRHZ CGR CUY CVF ECM EIF NPM 7QO 7SC 8FD FR3 JQ2 K9. L7M L~C L~D P64 RC3 7X8
ID	FETCH-LOGICAL-c348t-bd8376d51fa33d607b10a3d9d8afb068e5cde9326ebbe7a4bc490b3f9ca475e33
IEDL.DBID	TOX
ISICitedReferencesCount	45
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000891995500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1467-5463 1477-4054
IngestDate	Thu Oct 02 07:44:12 EDT 2025 Fri Oct 03 04:00:39 EDT 2025 Wed Feb 19 02:25:03 EST 2025 Sat Nov 29 05:43:34 EST 2025 Tue Nov 18 21:43:05 EST 2025 Wed Apr 02 06:58:29 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Siamese network synergistic drug combination random matrix projection cell line drug
Language	English
License	This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c348t-bd8376d51fa33d607b10a3d9d8afb068e5cde9326ebbe7a4bc490b3f9ca475e33
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-6795-4007 0000-0001-9028-5342
PMID	36418927
PQID	3113461735
PQPubID	26846
ParticipantIDs	proquest_miscellaneous_2739741798 proquest_journals_3113461735 pubmed_primary_36418927 crossref_citationtrail_10_1093_bib_bbac503 crossref_primary_10_1093_bib_bbac503 oup_primary_10_1093_bib_bbac503
PublicationCentury	2000
PublicationDate	2023-01-19
PublicationDateYYYYMMDD	2023-01-19
PublicationDate_xml	– month: 01 year: 2023 text: 2023-01-19 day: 19
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England – name: Oxford
PublicationTitle	Briefings in bioinformatics
PublicationTitleAlternate	Brief Bioinform
PublicationYear	2023
Publisher	Oxford University Press Oxford Publishing Limited (England)
Publisher_xml	– name: Oxford University Press – name: Oxford Publishing Limited (England)
References	Roth (2023011917142943900_ref15) 2017; 11 Jia (2023011917142943900_ref4) 2009; 8 Yadav (2023011917142943900_ref34) 2015; 13 Tan (2023011917142943900_ref35) 2012; 30 Wei (2023011917142943900_ref46) 2019 Ji (2023011917142943900_ref26) 2019; 10 Huang (2023011917142943900_ref6) 2017; 37 Swain (2023011917142943900_ref13) 2015; 372 Al-Lazikani (2023011917142943900_ref8) 2012; 30 Chou (2023011917142943900_ref5) 2006; 58 Madani Tonekaboni (2023011917142943900_ref18) 2018; 19 Bromley (2023011917142943900_ref44) 1993; 6 Eraslan (2023011917142943900_ref28) 2019; 20 Tallarida (2023011917142943900_ref12) 2006; 319 Csermely (2023011917142943900_ref3) 2013; 138 Hashemifar (2023011917142943900_ref50) 2018; 34 Hui (2023011917142943900_ref29) 2005 Mandelbrot (2023011917142943900_ref14) 2001; 285 Breiman (2023011917142943900_ref31) 2001; 45 Hinselmann (2023011917142943900_ref39) 2011 Gayvert (2023011917142943900_ref20) 2017; 13 Zagoruyko (2023011917142943900_ref45) 2015 Jeon (2023011917142943900_ref48) 2019; 35 O'Neil (2023011917142943900_ref33) 2016; 15 Su (2023011917142943900_ref49) 2022; 23 Chen (2023011917142943900_ref10) 2016; 12 Malyutina (2023011917142943900_ref21) 2019; 15 Klambauer (2023011917142943900_ref30) 2017 Loewe (2023011917142943900_ref37) 1953; 3 Preuer (2023011917142943900_ref23) 2017; 34 Cheng (2023011917142943900_ref24) 2019; 10 Hecht (2023011917142943900_ref11) 2009; 27 Bromley (2023011917142943900_ref47) 1993; 7 Celebi (2023011917142943900_ref19) 2019 Ding (2023011917142943900_ref25) 2019; 23 Tooker (2023011917142943900_ref7) 2007; 67 Bulusu (2023011917142943900_ref16) 2016; 21 Bliss (2023011917142943900_ref36) 1939 Zhang (2023011917142943900_ref27) 2019 Iorio (2023011917142943900_ref42) 2016; 166 Hochreiter (2023011917142943900_ref43) 2006; 22 Boyle (2023011917142943900_ref1) 2017; 169 Wu (2023011917142943900_ref17) 2022; 23 Amzallag (2023011917142943900_ref22) 2019 Di Veroli (2023011917142943900_ref38) 2016; 32 Singh (2023011917142943900_ref41) 2016; 90 JHJAoS (2023011917142943900_ref32) 2001 De Clercq (2023011917142943900_ref9) 2007; 6 Drazen (2023011917142943900_ref2) 2017; 377 Cao (2023011917142943900_ref40) 2013; 29
References_xml	– volume: 3 start-page: 285 year: 1953 ident: 2023011917142943900_ref37 article-title: The problem of synergism and antagonism of combined drugs publication-title: Arzneimittelforschung – start-page: 585 volume-title: Ann. Appl. Biol. year: 1939 ident: 2023011917142943900_ref36 article-title: The toxicity of poisons applied jointly – volume: 169 start-page: 1177 year: 2017 ident: 2023011917142943900_ref1 article-title: An expanded view of complex traits: from polygenic to omnigenic publication-title: Cell doi: 10.1016/j.cell.2017.05.038 – volume: 10 start-page: 1197 year: 2019 ident: 2023011917142943900_ref24 article-title: Network-based prediction of drug combinations publication-title: Nat Commun doi: 10.1038/s41467-019-09186-x – start-page: 5764 year: 2019 ident: 2023011917142943900_ref46 article-title: Inverse discriminative networks for handwritten signature verification publication-title: Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) – start-page: 4353 year: 2015 ident: 2023011917142943900_ref45 article-title: Learning to compare image patches via convolutional neural networks publication-title: Proceedings of the IEEE conference on computer vision and pattern recognition – volume: 30 start-page: 1125 year: 2012 ident: 2023011917142943900_ref35 article-title: Systematic identification of synergistic drug pairs targeting HIV publication-title: Nat Biotechnol doi: 10.1038/nbt.2391 – volume: 45 start-page: 5 year: 2001 ident: 2023011917142943900_ref31 article-title: Random forests publication-title: Mach Learn doi: 10.1023/A:1010933404324 – volume: 6 year: 1993 ident: 2023011917142943900_ref44 article-title: Signature verification using a "siamese" time delay neural network publication-title: Adv Neural Inf Process Syst – start-page: 1 volume-title: BMC Bioinform year: 2019 ident: 2023011917142943900_ref22 article-title: Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets – volume: 377 start-page: 62 year: 2017 ident: 2023011917142943900_ref2 article-title: Master protocols to study multiple therapies, multiple diseases, or both publication-title: N Engl J Med doi: 10.1056/NEJMra1510062 – start-page: S69 volume-title: Front Environ Sci year: 2017 ident: 2023011917142943900_ref30 article-title: DeepTox: toxicity prediction using deep learning – volume: 6 start-page: 1001 year: 2007 ident: 2023011917142943900_ref9 article-title: The design of drugs for HIV and HCV publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2424 – volume: 23 start-page: bbab355 year: 2022 ident: 2023011917142943900_ref17 article-title: Machine learning methods, databases and tools for drug combination prediction publication-title: Brief Bioinform doi: 10.1093/bib/bbab355 – volume: 10 start-page: 600 year: 2019 ident: 2023011917142943900_ref26 article-title: Five-feature model for developing the classifier for synergistic vs. antagonistic drug combinations built by XGBoost publication-title: Front Genet doi: 10.3389/fgene.2019.00600 – volume: 7 start-page: 669 year: 1993 ident: 2023011917142943900_ref47 article-title: Signature verification using a “siamese” time delay neural network publication-title: Int J Pattern Recogn Artif Intell doi: 10.1142/S0218001493000339 – volume: 15 year: 2019 ident: 2023011917142943900_ref21 article-title: Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1006752 – volume: 13 year: 2017 ident: 2023011917142943900_ref20 article-title: A computational approach for identifying synergistic drug combinations publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1005308 – volume: 20 start-page: 389 year: 2019 ident: 2023011917142943900_ref28 article-title: Deep learning: new computational modelling techniques for genomics publication-title: Nat Rev Genet doi: 10.1038/s41576-019-0122-6 – volume: 21 start-page: 225 year: 2016 ident: 2023011917142943900_ref16 article-title: Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives publication-title: Drug Discov Today doi: 10.1016/j.drudis.2015.09.003 – start-page: 1189 volume-title: Ann. Stat. year: 2001 ident: 2023011917142943900_ref32 article-title: Greedy function approximation: a gradient boosting machine – volume: 12 year: 2016 ident: 2023011917142943900_ref10 article-title: NLLSS: predicting synergistic drug combinations based on semi-supervised learning publication-title: PLoS Comput Biol doi: 10.1371/journal.pcbi.1004975 – volume: 15 start-page: 1155 year: 2016 ident: 2023011917142943900_ref33 article-title: An unbiased oncology compound screen to identify novel combination strategies publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-15-0843 – volume: 35 start-page: 5249 year: 2019 ident: 2023011917142943900_ref48 article-title: ReSimNet: drug response similarity prediction using Siamese neural networks publication-title: Bioinformatics doi: 10.1093/bioinformatics/btz411 – volume: 319 start-page: 1 year: 2006 ident: 2023011917142943900_ref12 article-title: An overview of drug combination analysis with isobolograms publication-title: J Pharmacol Exp Therap doi: 10.1124/jpet.106.104117 – volume: 166 start-page: 740 year: 2016 ident: 2023011917142943900_ref42 article-title: A landscape of pharmacogenomic interactions in cancer publication-title: Cell doi: 10.1016/j.cell.2016.06.017 – volume: 8 start-page: 111 year: 2009 ident: 2023011917142943900_ref4 article-title: Mechanisms of drug combinations: interaction and network perspectives publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2683 – volume: 27 start-page: 672 year: 2009 ident: 2023011917142943900_ref11 article-title: A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.8135 – start-page: 1 volume-title: Journal of cheminformatics year: 2011 ident: 2023011917142943900_ref39 article-title: jCompoundMapper: an open source Java library and command-line tool for chemical fingerprints – volume: 13 start-page: 504 year: 2015 ident: 2023011917142943900_ref34 article-title: Searching for drug synergy in complex dose–response landscapes using an interaction potency model publication-title: Comput Struct Biotechnol J doi: 10.1016/j.csbj.2015.09.001 – start-page: 67 volume-title: Synth Syst Biotechnol year: 2019 ident: 2023011917142943900_ref27 article-title: Synergistic drug combinations prediction by integrating pharmacological data – volume: 67 start-page: 4425 year: 2007 ident: 2023011917142943900_ref7 article-title: Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4495 – volume: 11 start-page: 301 year: 2017 ident: 2023011917142943900_ref15 article-title: Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma publication-title: Ann Oncol doi: 10.1023/A:1008342013224 – volume: 34 start-page: i802 year: 2018 ident: 2023011917142943900_ref50 article-title: Predicting protein–protein interactions through sequence-based deep learning publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty573 – volume: 23 start-page: 1336 year: 2019 ident: 2023011917142943900_ref25 article-title: Ensemble prediction of synergistic drug combinations incorporating biological, chemical, pharmacological, and network knowledge publication-title: IEEE J Biomed Health Inform doi: 10.1109/JBHI.2018.2852274 – start-page: 1 volume-title: Sci Rep year: 2019 ident: 2023011917142943900_ref19 article-title: In-silico prediction of synergistic anti-cancer drug combinations using multi-omics data – volume: 22 start-page: 943 year: 2006 ident: 2023011917142943900_ref43 article-title: A new summarization method for Affymetrix probe level data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btl033 – start-page: 768 volume-title: J R Stat Soc Series B Stat Methodol J R STAT SOC B year: 2005 ident: 2023011917142943900_ref29 article-title: Regularization and variable selection via the elastic net – volume: 37 start-page: 705 year: 2017 ident: 2023011917142943900_ref6 article-title: Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression publication-title: Oncol Rep doi: 10.3892/or.2016.5315 – volume: 58 start-page: 621 year: 2006 ident: 2023011917142943900_ref5 article-title: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies publication-title: Pharmacol Rev doi: 10.1124/pr.58.3.10 – volume: 34 start-page: 1538 year: 2017 ident: 2023011917142943900_ref23 article-title: DeepSynergy: predicting anti-cancer drug synergy with Deep Learning publication-title: Bioinformatics doi: 10.1093/bioinformatics/btx806 – volume: 32 start-page: 2866 year: 2016 ident: 2023011917142943900_ref38 article-title: Combenefit: an interactive platform for the analysis and visualization of drug combinations publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw230 – volume: 19 start-page: 263 year: 2018 ident: 2023011917142943900_ref18 article-title: Predictive approaches for drug combination discovery in cancer publication-title: Brief Bioinform doi: 10.1093/bib/bbw104 – volume: 138 start-page: 333 year: 2013 ident: 2023011917142943900_ref3 article-title: Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2013.01.016 – volume: 372 start-page: 724 year: 2015 ident: 2023011917142943900_ref13 article-title: Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1413513 – volume: 30 start-page: 679 year: 2012 ident: 2023011917142943900_ref8 article-title: Combinatorial drug therapy for cancer in the post-genomic era publication-title: Nat Biotechnol doi: 10.1038/nbt.2284 – volume: 285 start-page: 2083 year: 2001 ident: 2023011917142943900_ref14 article-title: Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1 publication-title: JAMA doi: 10.1001/jama.285.16.2083 – volume: 90 start-page: 1785 year: 2016 ident: 2023011917142943900_ref41 article-title: Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations publication-title: Arch Toxicol doi: 10.1007/s00204-015-1587-5 – volume: 23 start-page: bbab534 year: 2022 ident: 2023011917142943900_ref49 article-title: SRDFM: Siamese Response Deep Factorization Machine to improve anti-cancer drug recommendation publication-title: Brief Bioinform doi: 10.1093/bib/bbab534 – volume: 29 start-page: 1092 year: 2013 ident: 2023011917142943900_ref40 article-title: ChemoPy: freely available python package for computational biology and chemoinformatics publication-title: Bioinformatics doi: 10.1093/bioinformatics/btt105
SSID	ssj0020781
Score	2.5591056
Snippet	Abstract Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach... Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was...
SourceID	proquest pubmed crossref oup
SourceType	Aggregation Database Index Database Enrichment Source Publisher
SubjectTerms	Anticancer properties Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antineoplastic drugs Artificial neural networks Cancer Computational Biology - methods Computer applications Computer Simulation Correlation coefficient Correlation coefficients Drug Combinations Drug Synergism In vitro methods and tests Information processing Multilayer perceptrons Multilayers Predictions Software Toxicity
Title	SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction
URI	https://www.ncbi.nlm.nih.gov/pubmed/36418927 https://www.proquest.com/docview/3113461735 https://www.proquest.com/docview/2739741798
Volume	24
WOSCitedRecordID	wos000891995500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 1477-4054 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0020781 issn: 1467-5463 databaseCode: TOX dateStart: 20000101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEB-0KPhi_axX27pCn4TQJJPNZvtWTosvnsVWuLewn-WgTSS5E_tH-D93NtkeVIv2LZAZJuzMZudj5zcA-yg994bzhP59mBTapIkiRyOx3kuVWu-MGIdNiNmsms_lSbwg299Rwpd4oBf6QGtl-ADqmfEqmPPZ1_k6rgp4NWMTkUgCuntsw_uD99bBc6uZ7S-fcjhbjjfv-1XP4Gn0HtnRqO7n8MA1L-DxOE_y6iX8Pp19-3JyNP04PWRmGNcQU31sGHjDfGtWvbOsbdjpIlyPdawZr4Ez1VhGx5ZtL9llQO3_xWKOhviJryOCkPUmE-lYfxUaBgeEZ2a71XmQRQH2IIvYQuknPL6C78efzqafkzhvITFYVMtEW4pWS8szrxBtmQqdpQqttJXyOi0rx411wd9zWjuhSLGFTDV6aVQhuEN8DRtN27g3wLzTBTqBGk1aaArpylxQpJhba_JcKzGBDzfKqE0EIw8zMS7qsSiONa1vHdd3Avtr4h8jBsfdZO9Iq_-m2LnReB23al9jlmFBfhzyCbxfv6ZNFionqnHtqq_Jx6O4K2C7TWBrtJS1HCyLrJK52P6v-LfwJAyrDwmcTO7AxrJbuV14ZH4uF323Bw_FvNobLPsar033xg
linkProvider	Oxford University Press
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SNRMPACDC%3A+computational+model+focused+on+Siamese+network+and+random+matrix+projection+for+anticancer+synergistic+drug+combination+prediction&rft.jtitle=Briefings+in+bioinformatics&rft.au=Li%2C+Tian-Hao&rft.au=Wang%2C+Chun-Chun&rft.au=Zhang%2C+Li&rft.au=Chen%2C+Xing&rft.date=2023-01-19&rft.eissn=1477-4054&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1093%2Fbib%2Fbbac503&rft_id=info%3Apmid%2F36418927&rft.externalDocID=36418927
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1467-5463&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1467-5463&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1467-5463&client=summon